A Systematic Review to Clarify the Prognostic Values of CD44 and CD44<sup>+</sup>CD24<sup>-</sup> Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead. The gene discussed is CD24; the disease is breast carcinoma.